SURGICAL OUTCOMES OF RETROPERITONEAL LAPAROSCOPIC RADICAL NEPHRECTOMY FOR THE TREATMENT OF RENAL CELL CARCINOMA AT VIETDUC UNIVERSITY HOSPITAL

Huy Bình Trần, Trường Thành Đỗ, Trần Thanh Liêm Đặng, Hoàng Diệu Nguyễn

Main Article Content

Abstract

Objectives: Describe the clinical and paraclinical characteristics of patients with renal cell carcinoma (RCC) and to evaluate the outcomes of retroperitoneal laparoscopic radical nephrectomy for the treatment of RCC at VietDuc University Hospital during the period 2019-2024. Material and method: Retrospective case series 107 patients with RCC who underwent retroperitoneal laparoscopic radical nephrectomy from January 2019 to June 2024. Results: The average age in the study was 55.9±13.2 years. The male-to-female ratio was 1.5:1. Symptoms at hospital admission: lumbar pain 51.4%, gross hematuria 17.76%, palpable mass 2.85%, and 2 patients with three symptoms, 51 patients were asymptomatic (47.7%). Systemic symptoms such as fever, weight loss, and anemia were observed in 2 patients (1.9%), 11 patients (10.3%), and 11 patients (10.3%). Tumors were located in the right and left kidneys in 49.5% and 50.5% of cases, respectively. On computed tomography (CT), the average tumor size was 52.1±16.7mm, 11.2% calcified tumors, no renal vein thrombosis. Classification: cT1bN0M0 56.1% and cT1aN0M0 23.4%. According to Clavien-Dindo classification, 88.8% of patients had good, 9.3% moderate, and 1.9% poor. Long-term follow-up: 4 patients were lost to follow-up, 3 cancer-related deaths (2.9%), 3 local recurrences (2.9%), 1 patient (0.97%) with brain and lung metastases. Conclusion: Renal cell carcinoma may not have obvious clinical manifestations. Retroperitoneal laparoscopic radical nephrectomy for renal cell carcinoma can be performed safely and effectively

Article Details

References

1. Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update. European Urology. 2019;75(5):799-810.
2. Clayman RV, Kavoussi LR, Soper NJ, et al. Laparoscopic nephrectomy. N Engl J Med. 1991;324(19):1370-1371.
3. Trương Thanh Tùng. (2018). Phẫu thuật nội soi cắt bán phần thận trong điều trị u thận: Kinh nghiệm bước đầu tại bệnh viện đa khoa Tỉnh Thanh Hóa, Tạp chí Y Dược học quân sự. số 2. 63-70.
4. Padala SA, Barsouk A, Thandra KC, et al. Epidemiology of Renal Cell Carcinoma. World J Oncol. 2020;11(3):79-87.
5. Hemal AK, Kumar A, Kumar R, Wadhwa P, Seth A, Gupta NP. Laparoscopic versus open radical nephrectomy for large renal tumors: a long-term prospective comparison. J Urol. 2007;177(3):862-866.
6. Nguyễn Huy Hoàng. “Đánh giá kết quả phẫu thuật nội soi sau phúc mạc cắt thận triệt căn điều trị ung thư biểu mô tế bào thận tại bệnh viện hữu nghị Việt Đức”. (2023), luận văn tiến sỹ y học, trường Đại học Y Hà Nội.
7. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
8. Saika T, Ono Y, Hattori R, et al. Long-term outcome of laparoscopic radical nephrectomy for pathologic T1 renal cell carcinoma. Urology. 2003;62(6):1018-1023.
9. Janetschek G, Jeschke K, Peschel R, Strohmeyer D, Henning K, Bartsch G. Laparoscopic surgery for stage T1 renal cell carcinoma: radical nephrectomy and wedge resection. Eur Urol. 2000;38(2):131-138.
10. Hoàng Long. Kết quả điều trị phẫu thuật cắt u thận rộng rãi qua nội soi sau phúc mạc, (2012) Tạp chí Y Dược lâm sàng 108. Số 5/2012:59-63.